| Autor: |
Stevens WBC; Department of Hematology, Radboud UMC Nijmegen, the Netherlands., Los-de Vries GT; Department of Pathology, Amsterdam UMC location Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands., Langois-Jacques C; Université Lyon 1, Villeurbanne, France.; CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, Villeurbanne, France.; Hospices Civils de Lyon, Pôle Santé Publique, Service de Biostatistique et Bioinformatique, Lyon, France., Clear AJ; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary, University of London, United Kingdom., Stathi P; Department of Pathology, Amsterdam UMC location Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands., Sander B; Division of Pathology, Department of Laboratory Medicine, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden., Rosenwald A; Institute of Pathology, University of Würzburg, Germany.; Comprehensive Cancer Center Mainfranken, Würzburg, Germany., Calaminici M; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary, University of London, United Kingdom., Hoster E; Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), LMU University, Munich, Germany.; Department of Medicine III, LMU University Hospital, Munich, Germany., Hiddemann W; Department of Medicine III, LMU University Hospital, Munich, Germany., Gaulard P; Department of Pathology, Henri Mondor University Hospital, APHP, INSERM U955, Université Paris-Est, Créteil, France., Salles G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Klapper W; Institute of Pathology, University of Schleswig-Holstein, Kiel, Germany., Xerri L; Département de Biopathologie, Institut Paoli-Calmettes, Marseille, France., Burton C; Haematological Malignancy Diagnostic Service, St James University Hospital, Leeds, United Kingdom., Tooze RM; Division of Haematology & Immunology, Leeds Institute of Medical Research, University of Leeds, United Kingdom., Smith AG; Epidemiology & Cancer Statistics Group, Department of Health Sciences, University of York, United Kingdom., Buske C; Institute of Experimental Cancer Research, CCC Ulm, Universitäts Klinikum Ulm, Germany., Scott DW; BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada., Natkunam Y; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford, CA, USA., Advani R; Stanford Cancer Institute, Stanford, CA, USA.; Department of Hematology, Stanford University School of Medicine, Stanford, CA, USA., Sehn LH; BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada., Raemaekers J; Department of Hematology, Radboud UMC Nijmegen, the Netherlands., Gribben J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary, University of London, United Kingdom., Lockmer S; Division of Hematology, Department of Medicine, Karolinska Institute, Stockholm, Sweden., Kimby E; Division of Hematology, Department of Medicine, Karolinska Institute, Stockholm, Sweden., Kersten MJ; Department of Hematology, Amsterdam UMC location University of Amsterdam, Cancer Center Amsterdam, the Netherlands., Maucort-Boulch D; Université Lyon 1, Villeurbanne, France.; CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, Villeurbanne, France.; Hospices Civils de Lyon, Pôle Santé Publique, Service de Biostatistique et Bioinformatique, Lyon, France., Ylstra B; Department of Pathology, Amsterdam UMC location Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands., van Dijk E; Department of Pathology, Amsterdam UMC location Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands., de Jong D; Department of Pathology, Amsterdam UMC location Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands. |
Plný text